{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:29:25Z","timestamp":1790015365850,"version":"4.0.1"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"DOI":"10.1007\/s13300-025-01699-7","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T05:18:46Z","timestamp":1739164726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Role of Inflammation in the Pathogenesis of Diabetic Peripheral Neuropathy: New Lessons from Experimental Studies and Clinical Implications"],"prefix":"10.1007","author":[{"given":"Theodoros","family":"Panou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Gouveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djordje S.","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Papazoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7320-785X","authenticated-orcid":false,"given":"Nikolaos","family":"Papanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"1699_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11892-019-1212-8","volume":"19","author":"CW Hicks","year":"2019","unstructured":"Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diabetes Rep. 2019;19:86.","journal-title":"Curr Diabetes Rep"},{"key":"1699_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108932","volume":"177","author":"G Samakidou","year":"2021","unstructured":"Samakidou G, Eleftheriadou I, Tentolouris A, Papanas N, Tentolouris N. Rare diabetic neuropathies: it is not only distal symmetric polyneuropathy. Diabetes Res Clin Pract. 2021;177: 108932.","journal-title":"Diabetes Res Clin Pract"},{"issue":"Supplement_1","key":"1699_CR3","doi-asserted-by":"publisher","first-page":"S252","DOI":"10.2337\/dc25-S012","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee. 12. Retinopathy, neuropathy, and foot care: standards of care in diabetes\u20142025. Diabetes Care. 2025;48(Supplement_1):S252\u201365.","journal-title":"Diabetes Care"},{"key":"1699_CR4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41574-021-00496-z","volume":"17","author":"G Sloan","year":"2021","unstructured":"Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol. 2021;17:400\u201320.","journal-title":"Nat Rev Endocrinol"},{"key":"1699_CR5","doi-asserted-by":"publisher","first-page":"1265372","DOI":"10.3389\/fendo.2023.1265372","volume":"14","author":"J Zhu","year":"2024","unstructured":"Zhu J, Hu Z, Luo Y, et al. Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. Front Endocrinol (Lausanne). 2024;14:1265372.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1699_CR6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.21037\/apm-22-693","volume":"12","author":"MC Chang","year":"2023","unstructured":"Chang MC, Yang S. Diabetic peripheral neuropathy essentials: a narrative review. Ann Palliat Med. 2023;12:390\u20138.","journal-title":"Ann Palliat Med"},{"key":"1699_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2337\/dc16-2042","volume":"40","author":"R Pop-Busui","year":"2017","unstructured":"Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40:136\u201354.","journal-title":"Diabetes Care"},{"key":"1699_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11892-013-0375-y","volume":"13","author":"E Lontchi-Yimagou","year":"2013","unstructured":"Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP. Diabetes mellitus and inflammation. Curr Diab Rep. 2013;13:435\u201344.","journal-title":"Curr Diab Rep"},{"key":"1699_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115734","volume":"168","author":"SA Antar","year":"2023","unstructured":"Antar SA, Ashour NA, Sharaky M, et al. Diabetes mellitus: classification, mediators, and complications; a gate to identify potential targets for the development of new effective treatments. Biomed Pharmacother. 2023;168: 115734.","journal-title":"Biomed Pharmacother"},{"issue":"Suppl 1","key":"1699_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110764","volume":"206","author":"D Ziegler","year":"2023","unstructured":"Ziegler D. Pathogenetic treatments for diabetic peripheral neuropathy. Diabetes Res Clin Pract. 2023;206(Suppl 1):110764.","journal-title":"Diabetes Res Clin Pract"},{"key":"1699_CR11","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s12035-016-9702-z","volume":"54","author":"ZP Mu","year":"2017","unstructured":"Mu ZP, Wang YG, Li CQ, et al. Association between tumor necrosis factor-\u03b1 and diabetic peripheral neuropathy in patients with type\u00a02 diabetes: a meta-analysis. Mol Neurobiol. 2017;54:983\u201396.","journal-title":"Mol Neurobiol"},{"key":"1699_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.bbi.2014.05.009","volume":"41","author":"KL Ortmann","year":"2014","unstructured":"Ortmann KL, Chattopadhyay M. Decrease in neuroimmune activation by HSV-mediated gene transfer of TNF\u03b1 soluble receptor alleviates pain in rats with diabetic neuropathy. Brain Behav Immun. 2014;41:144\u201351.","journal-title":"Brain Behav Immun"},{"key":"1699_CR13","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s11011-018-0241-3","volume":"33","author":"N Namazi Sarvestani","year":"2018","unstructured":"Namazi Sarvestani N, Saberi Firouzi S, Falak R, et al. Phosphodiesterase\u00a04 and 7 inhibitors produce protective effects against high glucose-induced neurotoxicity in PC12 cells via modulation of the oxidative stress, apoptosis and inflammation pathways. Metab Brain Dis. 2018;33:1293\u2013306.","journal-title":"Metab Brain Dis"},{"key":"1699_CR14","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/jnen\/nlaa127","volume":"79","author":"AMF Shayea","year":"2020","unstructured":"Shayea AMF, Mousa AMA, Renno WM, et al. Chronic treatment with hydrogen sulfide donor gyy4137 mitigates microglial and astrocyte activation in the spinal cord of streptozotocin-induced diabetic rats. J Neuropathol Exp Neurol. 2020;79:1320\u201343.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1699_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/fcp.12839","volume":"37","author":"S Mokhtari","year":"2023","unstructured":"Mokhtari S, Sistani Karampour N, Shams MH, Dehpour AR, Hasanvand A. Protective assessment of progesterone and its receptor on experimental diabetic neuropathy: antioxidant and anti-inflammatory effects. Fundam Clin Pharmacol. 2023;37:287\u201395.","journal-title":"Fundam Clin Pharmacol"},{"key":"1699_CR16","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.2337\/db19-1084","volume":"69","author":"X Xu","year":"2020","unstructured":"Xu X, Wang W, Wang Z, et al. DW14006 as a direct AMPK\u03b1 activator ameliorates diabetic peripheral neuropathy in mice. Diabetes. 2020;69:1974\u201388.","journal-title":"Diabetes"},{"key":"1699_CR17","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s12035-016-9824-3","volume":"54","author":"VG Yerra","year":"2017","unstructured":"Yerra VG, Areti A, Kumar A. Adenosine monophosphate-activated protein kinase abates hyperglycaemia-induced neuronal injury in experimental models of diabetic neuropathy: effects on mitochondrial biogenesis, autophagy and neuroinflammation. Mol Neurobiol. 2017;54:2301\u201312.","journal-title":"Mol Neurobiol"},{"key":"1699_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10787-016-0275-2","volume":"24","author":"A Hasanvand","year":"2016","unstructured":"Hasanvand A, Amini-Khoei H, Hadian MR, et al. Anti-inflammatory effect of AMPK signaling pathway in rat model of diabetic neuropathy. Inflammopharmacology. 2016;24:207\u201319.","journal-title":"Inflammopharmacology"},{"key":"1699_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12576-020-00769-8","volume":"70","author":"HY Tang","year":"2020","unstructured":"Tang HY, Wang FJ, Ma JL, Wang H, Shen GM, Jiang AJ. Acupuncture attenuates the development of diabetic peripheral neuralgia by regulating P2X4 expression and inflammation in rat spinal microglia. J Physiol Sci. 2020;70:45.","journal-title":"J Physiol Sci"},{"key":"1699_CR20","doi-asserted-by":"publisher","first-page":"1203677","DOI":"10.3389\/fendo.2023.1203677","volume":"14","author":"Y Yin","year":"2023","unstructured":"Yin Y, Wang L, Zhao L, Lin L, Shen X. Effect of 10.6 \u03bcm laser moxibustion on inflammation in diabetic peripheral neuropathy rats. Front Endocrinol (Lausanne). 2023;14:1203677.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1699_CR21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s10103-024-04171-3","volume":"39","author":"NL Ferreira","year":"2024","unstructured":"Ferreira NL, Rocha IRC, Chacur M. Unraveling the RAGE-NF-\u03baB pathway: implications for modulating inflammation in diabetic neuropathy through photobiomodulation therapy. Lasers Med Sci. 2024;39:222.","journal-title":"Lasers Med Sci"},{"key":"1699_CR22","first-page":"2543","volume":"7","author":"YL Chen","year":"2015","unstructured":"Chen YL, Chen KH, Yin TC, et al. Extracorporeal shock wave therapy effectively prevented diabetic neuropathy. Am J Transl Res. 2015;7:2543\u201360.","journal-title":"Am J Transl Res"},{"key":"1699_CR23","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2174\/1871530319666191022114139","volume":"20","author":"Z Hangping","year":"2020","unstructured":"Hangping Z, Ling H, Lijin J, et al. The preventive effect of IL-1beta antagonist on diabetic peripheral neuropathy. Endocr Metab Immune Disord Drug Targets. 2020;20:753\u20139.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"1699_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2022.101873","volume":"77","author":"T Wu","year":"2022","unstructured":"Wu T, Li X, Tu S, Tan W, Chen L. Curcumin protect Schwann cells from inflammation response and apoptosis induced by high glucose through the NF-\u03baB pathway. Tissue Cell. 2022;77:101873.","journal-title":"Tissue Cell"},{"key":"1699_CR25","first-page":"6264","volume":"15","author":"HS Lin","year":"2023","unstructured":"Lin HS, Yang CH, Yin TC, et al. Addition of adipose tissue-derived mesenchymal stem cells improves empagliflozin therapy for alleviating hyperglycemia\u2013induced neuropathy. Am J Transl Res. 2023;15:6264\u201385.","journal-title":"Am J Transl Res"},{"key":"1699_CR26","doi-asserted-by":"publisher","first-page":"9904","DOI":"10.1038\/s41598-017-09487-5","volume":"7","author":"AT Brini","year":"2017","unstructured":"Brini AT, Amodeo G, Ferreira LM, et al. Therapeutic effect of human adipose-derived stem cells and their secretome in experimental diabetic pain. Sci Rep. 2017;7:9904.","journal-title":"Sci Rep"},{"key":"1699_CR27","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.2147\/JPR.S264136","volume":"13","author":"BM Yanik","year":"2020","unstructured":"Yanik BM, Dauch JR, Cheng HT. Interleukin-10 reduces neurogenic inflammation and pain behavior in a mouse model of type\u00a02 diabetes. J Pain Res. 2020;13:3499\u2013512.","journal-title":"J Pain Res"},{"key":"1699_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1055\/a-0826-4374","volume":"128","author":"S Xu","year":"2020","unstructured":"Xu S, Bao W, Men X, et al. Interleukin-10 protects schwann cells against advanced glycation end products-induced apoptosis via NF-\u03baB suppression. Exp Clin Endocrinol Diabetes. 2020;128:89\u201396.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1699_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32623","volume":"10","author":"L Hou","year":"2024","unstructured":"Hou L, Ma J, Feng X, et al. Caffeic acid and diabetic neuropathy: investigating protective effects and insulin-like growth factor\u00a01 (IGF-1)-related antioxidative and anti-inflammatory mechanisms in mice. Heliyon. 2024;10:e32623.","journal-title":"Heliyon"},{"key":"1699_CR30","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/jcp.26009","volume":"233","author":"HC Chandramoorthy","year":"2018","unstructured":"Chandramoorthy HC, Bin-Jaliah I, Karari H, et al. MSCs ameliorates DPN induced cellular pathology via [Ca2+]i homeostasis and scavenging the pro-inflammatory cytokines. J Cell Physiol. 2018;233:1330\u201341.","journal-title":"J Cell Physiol"},{"key":"1699_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119697","volume":"279","author":"ES El-Sawaf","year":"2021","unstructured":"El-Sawaf ES, Saleh S, Abdallah DM, Ahmed KA, El-Abhar HS. Vitamin\u00a0D and rosuvastatin obliterate peripheral neuropathy in a type-2 diabetes model through modulating Notch1, Wnt-10\u03b1, TGF-\u03b2 and NRF-1 crosstalk. Life Sci. 2021;279:119697.","journal-title":"Life Sci"},{"key":"1699_CR32","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429267000231004111024","author":"F Tang","year":"2023","unstructured":"Tang F, Zhao B, Zhang L, et al. Co-treatment of astragaloside\u00a0IV with vitamin\u00a0D in diabetic peripheral neuropathic rats: protective effects and potential mechanisms. Curr Mol Pharmacol. 2023. https:\/\/doi.org\/10.2174\/0118761429267000231004111024.","journal-title":"Curr Mol Pharmacol"},{"key":"1699_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178011","volume":"12","author":"C Oses","year":"2017","unstructured":"Oses C, Olivares B, Ezquer M, et al. Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: potential application in the treatment of diabetic neuropathy. PLoS ONE. 2017;12: e0178011.","journal-title":"PLoS ONE"},{"key":"1699_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.690082","volume":"12","author":"X Pan","year":"2022","unstructured":"Pan X, Kaminga AC, Kinra S, et al. Chemokines in type\u00a01 diabetes mellitus. Front Immunol. 2022;12:690082.","journal-title":"Front Immunol"},{"key":"1699_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.622438","volume":"12","author":"X Pan","year":"2021","unstructured":"Pan X, Kaminga AC, Wen SW, Liu A. Chemokines in prediabetes and type\u00a02 diabetes: a meta-analysis. Front Immunol. 2021;12:622438.","journal-title":"Front Immunol"},{"key":"1699_CR36","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00210-020-01871-9","volume":"393","author":"T Mert","year":"2020","unstructured":"Mert T, Sahin E, Yaman S, Sahin M. Effects of immune cell-targeted treatments result from the suppression of neuronal oxidative stress and inflammation in experimental diabetic rats. Naunyn Schmiedebergs Arch Pharmacol. 2020;393:1293\u2013302.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1699_CR37","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1111\/dom.12950","volume":"19","author":"PD O'Brien","year":"2017","unstructured":"O\u2019Brien PD, Hinder LM, Parlee SD, et al. Dual CCR2\/CCR5 antagonist treatment attenuates adipose inflammation, but not microvascular complications in ob\/ob mice. Diabetes Obes Metab. 2017;19:1468\u201372.","journal-title":"Diabetes Obes Metab"},{"key":"1699_CR38","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.bbi.2019.05.020","volume":"80","author":"S Liu","year":"2019","unstructured":"Liu S, Liu X, Xiong H, et al. CXCL13\/CXCR5 signaling contributes to diabetes-induced tactile allodynia via activating pERK, pSTAT3, pAKT pathways and pro-inflammatory cytokines production in the spinal cord of male mice. Brain Behav Immun. 2019;80:711\u201324.","journal-title":"Brain Behav Immun"},{"key":"1699_CR39","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3389\/fimmu.2014.00470","volume":"5","author":"MJ Kraakman","year":"2014","unstructured":"Kraakman MJ, Murphy AJ, Jandeleit-Dahm K, Kammoun HL. Macrophage polarization in obesity and type\u00a02 diabetes: weighing down our understanding of macrophage function? Front Immunol. 2014;5:470.","journal-title":"Front Immunol"},{"key":"1699_CR40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1871530322666220630093359","volume":"23","author":"S Banu","year":"2023","unstructured":"Banu S, Sur D. Role of macrophage in type\u00a02 diabetes mellitus: macrophage polarization a new paradigm for treatment of type\u00a02 diabetes mellitus. Endocr Metab Immune Disord Drug Targets. 2023;23:2\u201311.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"1699_CR41","doi-asserted-by":"publisher","first-page":"1276225","DOI":"10.3389\/fendo.2023.1276225","volume":"14","author":"Y Yao","year":"2023","unstructured":"Yao Y, Li J, Zhou Y, et al. Macrophage\/microglia polarization for the treatment of diabetic retinopathy. Front Endocrinol (Lausanne). 2023;14:1276225.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1699_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.612981","volume":"12","author":"YS Lee","year":"2021","unstructured":"Lee YS, Gupta DP, Park SH, Yang HJ, Song GJ. Anti-inflammatory effects of dimethyl fumarate in microglia via an autophagy dependent pathway. Front Pharmacol. 2021;12:612981.","journal-title":"Front Pharmacol"},{"key":"1699_CR43","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00125-019-05043-0","volume":"63","author":"B Fan","year":"2020","unstructured":"Fan B, Li C, Szalad A, et al. Mesenchymal stromal cell-derived exosomes ameliorate peripheral neuropathy in a mouse model of diabetes. Diabetologia. 2020;63:431\u201343.","journal-title":"Diabetologia"},{"key":"1699_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/gt.2015.67","volume":"23","author":"ME Yalvac","year":"2016","unstructured":"Yalvac ME, Arnold WD, Braganza C, Chen L, Mendell JR, Sahenk Z. AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy. Gene Ther. 2016;23:95\u2013102.","journal-title":"Gene Ther"},{"key":"1699_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220250","volume":"14","author":"G Zhang","year":"2019","unstructured":"Zhang G, Bogdanova N, Gao T, Sheikh KA. Elimination of activating Fc\u03b3 receptors in spontaneous autoimmune peripheral polyneuropathy model protects from neuropathic disease. PLoS ONE. 2019;14:e0220250.","journal-title":"PLoS ONE"},{"key":"1699_CR46","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13287-020-01680-0","volume":"11","author":"C De Gregorio","year":"2020","unstructured":"De Gregorio C, Contador D, D\u00edaz D, et al. Human adipose-derived mesenchymal stem cell-conditioned medium ameliorates polyneuropathy and foot ulceration in diabetic BKS db\/db mice. Stem Cell Res Ther. 2020;11:168.","journal-title":"Stem Cell Res Ther"},{"key":"1699_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.891550","volume":"13","author":"DS Umbaugh","year":"2022","unstructured":"Umbaugh DS, Maciejewski JC, Wooten JS, Guilford BL. Neuronal inflammation is associated with changes in epidermal innervation in high fat fed mice. Front Physiol. 2022;13:891550.","journal-title":"Front Physiol"},{"key":"1699_CR48","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.metabol.2015.11.002","volume":"65","author":"P Baum","year":"2016","unstructured":"Baum P, Kosacka J, Estrela-Lopis I, et al. The role of nerve inflammation and exogenous iron load in experimental peripheral diabetic neuropathy (PDN). Metabolism. 2016;65:391\u2013405.","journal-title":"Metabolism"},{"key":"1699_CR49","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.neuroscience.2019.03.005","volume":"406","author":"S Paeschke","year":"2019","unstructured":"Paeschke S, Baum P, Toyka KV, et al. The role of iron and nerve inflammation in diabetes mellitus type\u00a02-induced peripheral neuropathy. Neuroscience. 2019;406:496\u2013509.","journal-title":"Neuroscience"},{"key":"1699_CR50","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/01616412.2018.1564191","volume":"41","author":"J Kosacka","year":"2019","unstructured":"Kosacka J, Woidt K, Toyka KV, et al. The role of dietary non-heme iron load and peripheral nerve inflammation in the development of peripheral neuropathy (PN) in obese non-diabetic leptin-deficient ob\/ob mice. Neurol Res. 2019;41:341\u201353.","journal-title":"Neurol Res"},{"key":"1699_CR51","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jnutbio.2015.05.005","volume":"26","author":"MY Li","year":"2015","unstructured":"Li MY, Wang YY, Cao R, et al. Dietary fish oil inhibits mechanical allodynia and thermal hyperalgesia in diabetic rats by blocking nuclear factor-\u03baB-mediated inflammatory pathways. J Nutr Biochem. 2015;26:1147\u201355.","journal-title":"J Nutr Biochem"},{"key":"1699_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2017.10.004","volume":"156","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Liu H, Liu J. Akt activation: a potential strategy to ameliorate insulin resistance. Diabetes Res Clin Pract. 2019;156:107092.","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"1699_CR53","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/glia.23755","volume":"68","author":"AR Hackett","year":"2020","unstructured":"Hackett AR, Strickland A, Milbrandt J. Disrupting insulin signaling in Schwann cells impairs myelination and induces a sensory neuropathy. Glia. 2020;68(5):963\u201378.","journal-title":"Glia"},{"key":"1699_CR54","first-page":"6905","volume":"22","author":"L Chen","year":"2018","unstructured":"Chen L, Gong HY, Xu L. PVT1 protects diabetic peripheral neuropathy via PI3K\/AKT pathway. Eur Rev Med Pharmacol Sci. 2018;22:6905\u201311.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1699_CR55","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/jphp.13157","volume":"71","author":"J Dong","year":"2019","unstructured":"Dong J, Li H, Bai Y, Wu C. Muscone ameliorates diabetic peripheral neuropathy through activating AKT\/mTOR signalling pathway. J Pharm Pharmacol. 2019;71:1706\u201313.","journal-title":"J Pharm Pharmacol"},{"key":"1699_CR56","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41419-021-03930-2","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhao S, Yuan Q, et al. TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K\/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression. Cell Death Dis. 2021;12:642.","journal-title":"Cell Death Dis"},{"key":"1699_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110691","volume":"200","author":"S Suren Garg","year":"2023","unstructured":"Suren Garg S, Kushwaha K, Dubey R, Gupta J. Association between obesity, inflammation and insulin resistance: insights into signaling pathways and therapeutic interventions. Diabetes Res Clin Pract. 2023;200:110691.","journal-title":"Diabetes Res Clin Pract"},{"key":"1699_CR58","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2147\/DMSO.S235011","volume":"13","author":"L Jian","year":"2020","unstructured":"Jian L, Yang G. Identification of key genes involved in diabetic peripheral neuropathy progression and associated with pancreatic cancer. Diabetes Metab Syndr Obes. 2020;13:463\u201376.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1699_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111514","volume":"128","author":"NH Eisa","year":"2024","unstructured":"Eisa NH, Helmy SA, El-Kashef DH, El-Sherbiny M, Elsherbiny NM. Pramipexole protects against diabetic neuropathy: ffect on oxidative stress, TLR4\/IRAK-1\/TRAF-6\/NF-\u03baB and downstream inflammatory mediators. Int Immunopharmacol. 2024;128:111514.","journal-title":"Int Immunopharmacol"},{"key":"1699_CR60","doi-asserted-by":"publisher","first-page":"6016272","DOI":"10.1155\/2018\/6016272","volume":"2018","author":"P Liu","year":"2018","unstructured":"Liu P, Yuan HB, Zhao S, et al. Activation of GABAB receptor suppresses diabetic neuropathic pain through Toll-like receptor\u00a04 signaling pathway in the spinal dorsal horn. Mediators Inflamm. 2018;2018:6016272.","journal-title":"Mediators Inflamm"},{"key":"1699_CR61","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3390\/ijms21030881","volume":"21","author":"V Thakur","year":"2020","unstructured":"Thakur V, Sadanandan J, Chattopadhyay M. High-mobility Group Box\u00a01 Protein signaling in painful diabetic neuropathy. Int J Mol Sci. 2020;21:881.","journal-title":"Int J Mol Sci"},{"key":"1699_CR62","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/cbin.11677","volume":"45","author":"B Pang","year":"2021","unstructured":"Pang B, Qiao L, Wang S, Guo X, Xie Y, Han L. MiR-214-3p plays a protective role in diabetic neuropathic rats by regulating Nav1.3 and TLR4. Cell Biol Int. 2021;45:2294\u2013303.","journal-title":"Cell Biol Int"},{"key":"1699_CR63","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.2147\/JPR.S164493","volume":"11","author":"R Grosick","year":"2018","unstructured":"Grosick R, Alvarado-Vazquez PA, Messersmith AR, Romero-Sandoval EA. High glucose induces a priming effect in macrophages and exacerbates the production of pro-inflammatory cytokines after a challenge. J Pain Res. 2018;11:1769\u201378.","journal-title":"J Pain Res"},{"key":"1699_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174607","volume":"912","author":"B Zhao","year":"2021","unstructured":"Zhao B, Zhang Q, Liang X, Xie J, Sun Q. Quercetin reduces inflammation in a rat model of diabetic peripheral neuropathy by regulating the TLR4\/MyD88\/NF-\u03baB signalling pathway. Eur J Pharmacol. 2021;912:174607.","journal-title":"Eur J Pharmacol"},{"key":"1699_CR65","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mcn.2016.01.006","volume":"72","author":"V Thakur","year":"2016","unstructured":"Thakur V, Gonzalez M, Pennington K, Chattopadhyay M. Viral vector mediated continuous expression of interleukin-10 in DRG alleviates pain in type\u00a01 diabetic animals. Mol Cell Neurosci. 2016;72:46\u201353.","journal-title":"Mol Cell Neurosci"},{"key":"1699_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.112967","volume":"320","author":"S Elzinga","year":"2019","unstructured":"Elzinga S, Murdock BJ, Guo K, et al. Toll-like receptors and inflammation in metabolic neuropathy; a role in early versus late disease? Exp Neurol. 2019;320:112967.","journal-title":"Exp Neurol"},{"key":"1699_CR67","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1007\/s11064-021-03365-3","volume":"46","author":"J Tian","year":"2021","unstructured":"Tian J, Song T, Wang H, Wang W, Ma X, Hu Y. Toll-Like receptor\u00a02 antagonist ameliorates type\u00a02 diabetes mellitus associated neuropathic pain by repolarizing pro-inflammatory macrophages. Neurochem Res. 2021;46:2276\u201384.","journal-title":"Neurochem Res"},{"key":"1699_CR68","doi-asserted-by":"publisher","first-page":"1052756","DOI":"10.3389\/fimmu.2023.1052756","volume":"14","author":"S Lu","year":"2023","unstructured":"Lu S, Li Y, Qian Z, et al. Role of the inflammasome in insulin resistance and type\u00a02 diabetes mellitus. Front Immunol. 2023;14:1052756.","journal-title":"Front Immunol"},{"key":"1699_CR69","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.3390\/cells9081812","volume":"9","author":"S Menini","year":"2020","unstructured":"Menini S, Iacobini C, Vitale M, Pugliese G. The inflammasome in chronic complications of diabetes and related metabolic disorders. Cells. 2020;9:1812.","journal-title":"Cells"},{"key":"1699_CR70","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2147\/DMSO.S199802","volume":"12","author":"C Zhang","year":"2019","unstructured":"Zhang C, Zhu X, Li L, et al. A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation. Diabetes Metab Syndr Obes. 2019;12:1297\u2013309.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1699_CR71","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.2147\/DMSO.S222053","volume":"12","author":"Z Wan","year":"2019","unstructured":"Wan Z, Fan Y, Liu X, et al. NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis. Diabetes Metab Syndr Obes. 2019;12:1931\u201342.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1699_CR72","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1152\/jn.00239.2023","volume":"130","author":"D Impellizzeri","year":"2023","unstructured":"Impellizzeri D, Siracusa R, D\u2019Amico R, et al. A\u00e7a\u00ed berry ameliorates cognitive impairment by inhibiting NLRP3\/ASC\/CASP axis in STZ-induced diabetic neuropathy in mice. J Neurophysiol. 2023;130:671\u201383.","journal-title":"J Neurophysiol"},{"key":"1699_CR73","doi-asserted-by":"publisher","DOI":"10.1590\/s0102-865020190110000005","volume":"34","author":"L Kang","year":"2019","unstructured":"Kang L, Yayi H, Fang Z, Bo Z, Zhongyuan X. Dexmedetomidine attenuates P2X4 and NLRP3 expression in the spine of rats with diabetic neuropathic pain. Acta Cir Bras. 2019;34:e201901105.","journal-title":"Acta Cir Bras"},{"key":"1699_CR74","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s12964-024-01723-6","volume":"22","author":"Q Liao","year":"2024","unstructured":"Liao Q, Yang Y, Li Y, et al. Targeting TANK-binding kinase\u00a01 attenuates painful diabetic neuropathy via inhibiting microglia pyroptosis. Cell Commun Signal. 2024;22:368.","journal-title":"Cell Commun Signal"},{"key":"1699_CR75","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1248\/bpb.b22-00680","volume":"46","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li C, Wang Z, Wang T, Zhou Y, Zheng L. Blocking CXC motif chemokine ligand 2 ameliorates diabetic peripheral neuropathy via inhibiting apoptosis and NLRP3 inflammasome activation. Biol Pharm Bull. 2023;46:672\u201383.","journal-title":"Biol Pharm Bull"},{"key":"1699_CR76","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.2174\/1381612823666170125153334","volume":"23","author":"R Aditya","year":"2017","unstructured":"Aditya R, Kiran AR, Varma DS, Vemuri R, Gundamaraju R. A review on SIRtuins in diabetes. Curr Pharm Des. 2017;23:2299\u2013307.","journal-title":"Curr Pharm Des"},{"key":"1699_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122187","volume":"333","author":"J Chen","year":"2023","unstructured":"Chen J, Wang Q, Li R, et al. The role of sirtuins in the regulatin of oxidative stress during the progress and therapy of type\u00a02 diabetes mellitus. Life Sci. 2023;333:122187.","journal-title":"Life Sci"},{"key":"1699_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14913","volume":"30","author":"Y Li","year":"2024","unstructured":"Li Y, Kong E, Ding R, et al. Hyperglycemia-induced SIRT3 downregulation increases microglial aerobic glycolysis and inflammation in diabetic neuropathic pain pathogenesis. CNS Neurosci Ther. 2024;30:e14913.","journal-title":"CNS Neurosci Ther"},{"key":"1699_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2023.102014","volume":"81","author":"RE Ghoweba","year":"2023","unstructured":"Ghoweba RE, Khowailed AA, Aboulhoda BE, Rashed LA, Selmy A. Synergistic role of resveratrol and exercise training in management of diabetic neuropathy and myopathy via SIRT1\/NGF\/GAP43 linkage. Tissue Cell. 2023;81:102014.","journal-title":"Tissue Cell"},{"key":"1699_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2022.112064","volume":"172","author":"AA Syed","year":"2023","unstructured":"Syed AA, Reza MI, Yadav H, Gayen JR. Hesperidin inhibits NOX4 mediated oxidative stress and inflammation by upregulating SIRT1 in experimental diabetic neuropathy. Exp Gerontol. 2023;172:112064.","journal-title":"Exp Gerontol"},{"key":"1699_CR81","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.3390\/ijms21249739","volume":"21","author":"GA Cabral-Pacheco","year":"2020","unstructured":"Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, et al. The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci. 2020;21:9739.","journal-title":"Int J Mol Sci"},{"key":"1699_CR82","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.jpain.2019.04.010","volume":"20","author":"K Resham","year":"2019","unstructured":"Resham K, Sharma SS. Pharmacologic inhibition of porcupine, disheveled, and \u03b2-catenin in wnt signaling pathway ameliorates diabetic peripheral neuropathy in rats. J Pain. 2019;20:1338\u201352.","journal-title":"J Pain"},{"key":"1699_CR83","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.expneurol.2018.03.011","volume":"305","author":"LM Hinder","year":"2018","unstructured":"Hinder LM, Murdock BJ, Park M, et al. Transcriptional networks of progressive diabetic peripheral neuropathy in the db\/db mouse model of type\u00a02 diabetes: an inflammatory story. Exp Neurol. 2018;305:33\u201343.","journal-title":"Exp Neurol"},{"key":"1699_CR84","doi-asserted-by":"publisher","first-page":"dmm050080","DOI":"10.1242\/dmm.050080","volume":"16","author":"SE Elzinga","year":"2023","unstructured":"Elzinga SE, Eid SA, McGregor BA, et al. Transcriptomic analysis of diabetic kidney disease and neuropathy in mouse models of type\u00a01 and type\u00a02 diabetes. Dis Model Mech. 2023;16:dmm050080.","journal-title":"Dis Model Mech"},{"key":"1699_CR85","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1089\/ars.2017.7299","volume":"29","author":"TJ Guzik","year":"2018","unstructured":"Guzik TJ, Cosentino F. Epigenetics and immunometabolism in diabetes and aging. Antioxid Redox Signal. 2018;29:257\u201374.","journal-title":"Antioxid Redox Signal"},{"key":"1699_CR86","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3724\/abbs.2021016","volume":"54","author":"X Li","year":"2022","unstructured":"Li X, Lu L, Hou W, et al. Epigenetics in the pathogenesis of diabetic nephropathy. Acta Biochim Biophys Sin (Shanghai). 2022;54:163\u201372.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"1699_CR87","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41581-019-0135-6","volume":"15","author":"M Kato","year":"2019","unstructured":"Kato M, Natarajan R. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory. Nat Rev Nephrol. 2019;15:327\u201345.","journal-title":"Nat Rev Nephrol"},{"key":"1699_CR88","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1007\/s12035-023-03701-4","volume":"61","author":"V Thakur","year":"2024","unstructured":"Thakur V, Gonzalez MA, Parada M, Martinez RD, Chattopadhyay M. Role of histone deacetylase inhibitor in diabetic painful neuropathy. Mol Neurobiol. 2024;61:2283\u201396.","journal-title":"Mol Neurobiol"},{"key":"1699_CR89","doi-asserted-by":"publisher","first-page":"5593608","DOI":"10.1155\/2021\/5593608","volume":"2021","author":"V Spallone","year":"2021","unstructured":"Spallone V, Ciccacci C, Latini A, Borgiani P. What is in the field for genetics and epigenetics of diabetic neuropathy: the role of microRNAs. J Diabetes Res. 2021;2021:5593608.","journal-title":"J Diabetes Res"},{"key":"1699_CR90","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.nano.2019.01.007","volume":"17","author":"Q Luo","year":"2019","unstructured":"Luo Q, Feng Y, Xie Y, et al. Nanoparticle-microRNA-146a-5p polyplexes ameliorate diabetic peripheral neuropathy by modulating inflammation and apoptosis. Nanomedicine. 2019;17:188\u201397.","journal-title":"Nanomedicine"},{"key":"1699_CR91","doi-asserted-by":"publisher","first-page":"1195145","DOI":"10.3389\/fendo.2023.1195145","volume":"14","author":"X Li","year":"2023","unstructured":"Li X, Dai A, Tran R, Wang J. Text mining-based identification of promising miRNA biomarkers for diabetes mellitus. Front Endocrinol (Lausanne). 2023;14:1195145.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1699_CR92","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/DDDT.S157109","volume":"12","author":"Y Feng","year":"2018","unstructured":"Feng Y, Chen L, Luo Q, Wu M, Chen Y, Shi X. Involvement of microRNA-146a in diabetic peripheral neuropathy through the regulation of inflammation. Drug Des Devel Ther. 2018;12:171\u20137.","journal-title":"Drug Des Devel Ther"},{"key":"1699_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113694","volume":"341","author":"B Fan","year":"2021","unstructured":"Fan B, Chopp M, Zhang ZG, Liu XS. Treatment of diabetic peripheral neuropathy with engineered mesenchymal stromal cell-derived exosomes enriched with microRNA-146a provide amplified therapeutic efficacy. Exp Neurol. 2021;341:113694.","journal-title":"Exp Neurol"},{"key":"1699_CR94","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000503325","volume":"26","author":"B Wu","year":"2019","unstructured":"Wu B, Guo Y, Chen Q, Xiong Q, Min S. MicroRNA-193a downregulates HMGB1 to alleviate diabetic neuropathic pain in a mouse model. NeuroImmunoModulation. 2019;26:250\u20137.","journal-title":"NeuroImmunoModulation"},{"key":"1699_CR95","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/neup.12852","volume":"43","author":"K Zglejc-Waszak","year":"2023","unstructured":"Zglejc-Waszak K, Schmidt AM, Juranek JK. The receptor for advanced glycation end products and its ligands\u2019 expression in OVE26 diabetic sciatic nerve during the development of length-dependent neuropathy. Neuropathology. 2023;43:84\u201394.","journal-title":"Neuropathology"},{"key":"1699_CR96","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jdiacomp.2015.09.018","volume":"30","author":"PD O'Brien","year":"2016","unstructured":"O\u2019Brien PD, Hur J, Robell NJ, Hayes JM, Sakowski SA, Feldman EL. Gender-specific differences in diabetic neuropathy in BTBR ob\/ob mice. J Diabetes Complications. 2016;30:30\u20137.","journal-title":"J Diabetes Complications"},{"key":"1699_CR97","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1530\/JME-19-0067","volume":"63","author":"J Chen","year":"2019","unstructured":"Chen J, Li C, Liu W, Yan B, Hu X, Yang F. miRNA-155 silencing reduces sciatic nerve injury in diabetic peripheral neuropathy. J Mol Endocrinol. 2019;63:227\u201338.","journal-title":"J Mol Endocrinol"},{"key":"1699_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173719","volume":"891","author":"X Zhang","year":"2021","unstructured":"Zhang X, Xia L, Xie A, Liao O, Ju F, Zhou Y. Low concentration of bupivacaine ameliorates painful diabetic neuropathy by mediating miR-23a\/PDE4B axis in microglia. Eur J Pharmacol. 2021;891:173719.","journal-title":"Eur J Pharmacol"},{"key":"1699_CR99","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.intimp.2019.01.050","volume":"70","author":"NM Elsherbiny","year":"2019","unstructured":"Elsherbiny NM, Ahmed E, Kader GA, et al. Inhibitory effect of valproate sodium on pain behavior in diabetic mice involves suppression of spinal histone deacetylase 1 and inflammatory mediators. Int Immunopharmacol. 2019;70:16\u201327.","journal-title":"Int Immunopharmacol"},{"key":"1699_CR100","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.bbrc.2014.12.004","volume":"456","author":"Q Gong","year":"2015","unstructured":"Gong Q, Lu Z, Huang Q, et al. Altered microRNAs expression profiling in mice with diabetic neuropathic pain. Biochem Biophys Res Commun. 2015;456:615\u201320.","journal-title":"Biochem Biophys Res Commun"},{"key":"1699_CR101","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005443","volume":"95","author":"Y Li","year":"2016","unstructured":"Li Y, Ma W, Xie C, et al. Identification of genes and signaling pathways associated with diabetic neuropathy using a weighted correlation network analysis: a consort study. Medicine (Baltimore). 2016;95:e5443.","journal-title":"Medicine (Baltimore)"},{"key":"1699_CR102","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2147\/DMSO.S242789","volume":"13","author":"Y Feng","year":"2020","unstructured":"Feng Y, Ge Y, Wu M, et al. Long non-coding rnas regulate inflammation in diabetic peripheral neuropathy by acting as cernas targeting miR-146a-5p. Diabetes Metab Syndr Obes. 2020;13:413\u201322.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1699_CR103","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11010-020-03923-3","volume":"476","author":"W Ren","year":"2021","unstructured":"Ren W, Xi G, Li X, et al. Long non-coding RNA HCG18 promotes M1 macrophage polarization through regulating the miR-146a\/TRAF6 axis, facilitating the progression of diabetic peripheral neuropathy. Mol Cell Biochem. 2021;476:471\u201382.","journal-title":"Mol Cell Biochem"},{"key":"1699_CR104","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.3390\/nu12092518","volume":"12","author":"T Karonova","year":"2020","unstructured":"Karonova T, Stepanova A, Bystrova A, Jude EB. High-dose vitamin\u00a0D supplementation improves microcirculation and reduces inflammation in diabetic neuropathy patients. Nutrients. 2020;12:2518.","journal-title":"Nutrients"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-025-01699-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-025-01699-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-025-01699-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T06:06:53Z","timestamp":1739167613000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-025-01699-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":104,"alternative-id":["1699"],"URL":"https:\/\/doi.org\/10.1007\/s13300-025-01699-7","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Theodoros Panou has nothing to disclose. Evanthia Gouveri has attended conferences sponsored by Berlin-Chemie, Sanofi, AstraZeneca, Novo Nordisk, Lilly and Boehringer Ingelheim; received speaker honoraria by Boehringer Ingelheim, Sanofi and Menarini. Djordje S. Popovic declares associations with: Abbott, Alkaloid, Amicus, AstraZeneca, Boehringer Ingelheim, Berlin-Chemie, Eli Lilly, Galenika, Krka, Merck, Novo Nordisk, PharmaSwiss, Sanofi-Aventis, Servier, Viatris, and W\u00f6rwag Pharma. Dimitrios Papazoglou declares associations: with Menarini, Novo Nordisk, AstraZeneca, Boehringer Ingelheim and Sanofi-Aventis. Nikolaos Papanas has been an advisory board member of AstraZeneca, Bayer, Boehringer Ingelheim, Menarini, MSD, Novo Nordisk, Pfizer, Takeda and TrigoCare International; has participated in sponsored studies by AstraZeneca, Eli Lilly, GSK, MSD, Novo Nordisk, Novartis and Sanofi-Aventis; has received honoraria as a speaker for AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Elpen, Menarini, MSD, Mylan, Novo Nordisk, Pfizer, Sanofi-Aventis and Vianex; and has attended conferences sponsored by TrigoCare International, Eli Lilly, Galenica, Menarini, Novo Nordisk, Pfizer and Sanofi-Aventis. Nikolaos Papanas is an Editorial Board member of Diabetes Therapy. Nikolaos Papanas was not involved in the selection of peer reviewers for the manuscript or any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}